Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: A novel paradigm for treatment assignment

Roland B. Walter, Megan Othus, Gautam Borthakur, Farhad Ravandi, Jorge E. Cortes, Sherry A. Pierce, Frederick R. Appelbaum, Hagop A. Kantarjian, Elihu H. Estey

Research output: Contribution to journalArticle

Abstract

Purpose: Outcome in acute myeloid leukemia (AML) worsens with age, at least in part because of higher treatment-related mortality (TRM) in older patients. Eligibility for intensive AML treatment protocols is therefore typically based on age as the implied principal predictor of TRM, although other health- and disease-related factors modulate this age effect. Patients and Methods: We empirically defined TRM using estimated weekly hazard rates in 3,365 adults of all ages administered intensive chemotherapy for newly diagnosed AML. We used the area under the receiver operator characteristic curve (AUC) to quantify the relative effects of age and other covariates on TRM in a subset of 2,238 patients. In this approach, an AUC of 1.0 denotes perfect prediction, whereas an AUC of 0.5 is analogous to a coin flip. Results: Regardless of age, risk of death declined once 4 weeks had elapsed from treatment start, suggesting that patients who die during this time comprise a qualitatively distinct group. Performance status (PS) and age were the most important individual predictors of TRM (AUCs of 0.75 and 0.65, respectively). However, multicomponent models were significantly more accurate in predicting TRM (AUC of 0.83) than PS or age alone. Elimination of age from such multicomponent models only minimally affected their predictive accuracy (AUC of 0.82). Conclusion: These data suggest that age is primarily a surrogate for other covariates, which themselves add significantly to predictive accuracy, thus challenging the wisdom of using age as primary or sole basis for assignment of intensive, curative intent treatment in AML.

Original languageEnglish (US)
Pages (from-to)4417-4423
Number of pages7
JournalJournal of Clinical Oncology
Volume29
Issue number33
DOIs
StatePublished - Nov 20 2011
Externally publishedYes

Fingerprint

Acute Myeloid Leukemia
Area Under Curve
Mortality
Therapeutics
Numismatics
Age Factors
Clinical Protocols
Drug Therapy
Health

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores : A novel paradigm for treatment assignment. / Walter, Roland B.; Othus, Megan; Borthakur, Gautam; Ravandi, Farhad; Cortes, Jorge E.; Pierce, Sherry A.; Appelbaum, Frederick R.; Kantarjian, Hagop A.; Estey, Elihu H.

In: Journal of Clinical Oncology, Vol. 29, No. 33, 20.11.2011, p. 4417-4423.

Research output: Contribution to journalArticle

Walter, Roland B. ; Othus, Megan ; Borthakur, Gautam ; Ravandi, Farhad ; Cortes, Jorge E. ; Pierce, Sherry A. ; Appelbaum, Frederick R. ; Kantarjian, Hagop A. ; Estey, Elihu H. / Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores : A novel paradigm for treatment assignment. In: Journal of Clinical Oncology. 2011 ; Vol. 29, No. 33. pp. 4417-4423.
@article{9e889cbc38f440b6b261241446df5631,
title = "Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: A novel paradigm for treatment assignment",
abstract = "Purpose: Outcome in acute myeloid leukemia (AML) worsens with age, at least in part because of higher treatment-related mortality (TRM) in older patients. Eligibility for intensive AML treatment protocols is therefore typically based on age as the implied principal predictor of TRM, although other health- and disease-related factors modulate this age effect. Patients and Methods: We empirically defined TRM using estimated weekly hazard rates in 3,365 adults of all ages administered intensive chemotherapy for newly diagnosed AML. We used the area under the receiver operator characteristic curve (AUC) to quantify the relative effects of age and other covariates on TRM in a subset of 2,238 patients. In this approach, an AUC of 1.0 denotes perfect prediction, whereas an AUC of 0.5 is analogous to a coin flip. Results: Regardless of age, risk of death declined once 4 weeks had elapsed from treatment start, suggesting that patients who die during this time comprise a qualitatively distinct group. Performance status (PS) and age were the most important individual predictors of TRM (AUCs of 0.75 and 0.65, respectively). However, multicomponent models were significantly more accurate in predicting TRM (AUC of 0.83) than PS or age alone. Elimination of age from such multicomponent models only minimally affected their predictive accuracy (AUC of 0.82). Conclusion: These data suggest that age is primarily a surrogate for other covariates, which themselves add significantly to predictive accuracy, thus challenging the wisdom of using age as primary or sole basis for assignment of intensive, curative intent treatment in AML.",
author = "Walter, {Roland B.} and Megan Othus and Gautam Borthakur and Farhad Ravandi and Cortes, {Jorge E.} and Pierce, {Sherry A.} and Appelbaum, {Frederick R.} and Kantarjian, {Hagop A.} and Estey, {Elihu H.}",
year = "2011",
month = "11",
day = "20",
doi = "10.1200/JCO.2011.35.7525",
language = "English (US)",
volume = "29",
pages = "4417--4423",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "33",

}

TY - JOUR

T1 - Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores

T2 - A novel paradigm for treatment assignment

AU - Walter, Roland B.

AU - Othus, Megan

AU - Borthakur, Gautam

AU - Ravandi, Farhad

AU - Cortes, Jorge E.

AU - Pierce, Sherry A.

AU - Appelbaum, Frederick R.

AU - Kantarjian, Hagop A.

AU - Estey, Elihu H.

PY - 2011/11/20

Y1 - 2011/11/20

N2 - Purpose: Outcome in acute myeloid leukemia (AML) worsens with age, at least in part because of higher treatment-related mortality (TRM) in older patients. Eligibility for intensive AML treatment protocols is therefore typically based on age as the implied principal predictor of TRM, although other health- and disease-related factors modulate this age effect. Patients and Methods: We empirically defined TRM using estimated weekly hazard rates in 3,365 adults of all ages administered intensive chemotherapy for newly diagnosed AML. We used the area under the receiver operator characteristic curve (AUC) to quantify the relative effects of age and other covariates on TRM in a subset of 2,238 patients. In this approach, an AUC of 1.0 denotes perfect prediction, whereas an AUC of 0.5 is analogous to a coin flip. Results: Regardless of age, risk of death declined once 4 weeks had elapsed from treatment start, suggesting that patients who die during this time comprise a qualitatively distinct group. Performance status (PS) and age were the most important individual predictors of TRM (AUCs of 0.75 and 0.65, respectively). However, multicomponent models were significantly more accurate in predicting TRM (AUC of 0.83) than PS or age alone. Elimination of age from such multicomponent models only minimally affected their predictive accuracy (AUC of 0.82). Conclusion: These data suggest that age is primarily a surrogate for other covariates, which themselves add significantly to predictive accuracy, thus challenging the wisdom of using age as primary or sole basis for assignment of intensive, curative intent treatment in AML.

AB - Purpose: Outcome in acute myeloid leukemia (AML) worsens with age, at least in part because of higher treatment-related mortality (TRM) in older patients. Eligibility for intensive AML treatment protocols is therefore typically based on age as the implied principal predictor of TRM, although other health- and disease-related factors modulate this age effect. Patients and Methods: We empirically defined TRM using estimated weekly hazard rates in 3,365 adults of all ages administered intensive chemotherapy for newly diagnosed AML. We used the area under the receiver operator characteristic curve (AUC) to quantify the relative effects of age and other covariates on TRM in a subset of 2,238 patients. In this approach, an AUC of 1.0 denotes perfect prediction, whereas an AUC of 0.5 is analogous to a coin flip. Results: Regardless of age, risk of death declined once 4 weeks had elapsed from treatment start, suggesting that patients who die during this time comprise a qualitatively distinct group. Performance status (PS) and age were the most important individual predictors of TRM (AUCs of 0.75 and 0.65, respectively). However, multicomponent models were significantly more accurate in predicting TRM (AUC of 0.83) than PS or age alone. Elimination of age from such multicomponent models only minimally affected their predictive accuracy (AUC of 0.82). Conclusion: These data suggest that age is primarily a surrogate for other covariates, which themselves add significantly to predictive accuracy, thus challenging the wisdom of using age as primary or sole basis for assignment of intensive, curative intent treatment in AML.

UR - http://www.scopus.com/inward/record.url?scp=81255175041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81255175041&partnerID=8YFLogxK

U2 - 10.1200/JCO.2011.35.7525

DO - 10.1200/JCO.2011.35.7525

M3 - Article

C2 - 21969499

AN - SCOPUS:81255175041

VL - 29

SP - 4417

EP - 4423

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 33

ER -